SMR | Conference

Adil Daud, MD, on the Importance of Testing Patients with Melanoma for BRAF Mutations
November 15, 2020

Adil Daud, MD, spoke about the emergence of next-generation sequencing and the importance of testing patients with melanoma for BRAF mutations.

Jeffrey Weber, MD, PhD, Describes Unmet Needs for Patients with Melanoma
November 14, 2020

Jeffrey Weber, MD, PhD, discusses the unmet needs professionals take into consideration when deciding treatment options for patients with melanoma.

Hussein Tawbi, MD, PhD, Discusses Results From the COMBI-AD Trial
November 13, 2020

Data from the COMBI-AD Trial evaluating dabrafenib and trametinib to treat melanoma was analyzed by Hussein Tawbi, MD, PhD, of The University of Texas MD Anderson Cancer Center.